Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer

Funct Integr Genomics. 2024 May 14;24(3):96. doi: 10.1007/s10142-024-01361-8.

Xiaoying Chen¹, Yue Yu², Yuting Su², Lizhou Shi², Shanzhou Xie¹, Yi Hong¹, Xia Liu^{3

4}, Fuqiang Yin^{5

6}

¹ Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Centre for Translational Medicine and School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, Guangxi, China.
² Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
³ Key Laboratory of Longevity and Ageing-Related Disease of Chinese Ministry of Education, Centre for Translational Medicine and School of Basic Medical Sciences, Guangxi Medical University, Nanning, 530021, Guangxi, China. realliuxia@sina.com.
⁴ Key Laboratory of Human Development and Disease Research (Guangxi Medical University), Education Department of Guangxi Zhang Autonomous Region, Nanning, 530021, Guangxi, China. realliuxia@sina.com.
⁵ Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China. yinfq@mail2.sysu.edu.cn.
⁶ Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, 530021, Guangxi, China. yinfq@mail2.sysu.edu.cn.

No abstract available

Publication types